Amedisys Balance Sheet Health
Financial Health criteria checks 6/6
Amedisys has a total shareholder equity of $1.2B and total debt of $353.2M, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are $2.1B and $938.7M respectively. Amedisys's EBIT is $208.9M making its interest coverage ratio 8.1. It has cash and short-term investments of $245.5M.
Key information
29.4%
Debt to equity ratio
US$353.21m
Debt
| Interest coverage ratio | 8.1x |
| Cash | US$245.45m |
| Equity | US$1.20b |
| Total liabilities | US$938.68m |
| Total assets | US$2.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ADY's short term assets ($579.9M) exceed its short term liabilities ($486.0M).
Long Term Liabilities: ADY's short term assets ($579.9M) exceed its long term liabilities ($452.7M).
Debt to Equity History and Analysis
Debt Level: ADY's net debt to equity ratio (9%) is considered satisfactory.
Reducing Debt: ADY's debt to equity ratio has reduced from 39.3% to 29.4% over the past 5 years.
Debt Coverage: ADY's debt is well covered by operating cash flow (59.9%).
Interest Coverage: ADY's interest payments on its debt are well covered by EBIT (8.1x coverage).